fda warning letter compounding semaglutide news issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA says 'no clinical need'

After the neonatal capsaicin treatment, a complete abolition of the gastroprotection caused by NaBPC157 was noted if NaBPC157 was applied as a single ng-regimen

"We raise our earnings estimate by 8-10 per cent for FY27/FY28, factoring in a healthy pace of product launches in core markets and improvement in profitability of the Cenexi business, and c) currency depreciation tailwinds

Other Side Effects You Should Know Muscle pain differs meaningfully from nausea, the most common tirzepatide side effect

Lipolysis triggers a systemic insulin response essential for efficient energy replenishment of activated brown adipose tissue in mice